HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suzanne F Jones Selected Research

dactolisib

4/2015A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suzanne F Jones Research Topics

Disease

42Neoplasms (Cancer)
11/2022 - 01/2002
9Thrombocytopenia (Thrombopenia)
12/2015 - 05/2003
8Nausea
03/2016 - 11/2005
8Neutropenia
12/2015 - 05/2003
8Diarrhea
08/2013 - 05/2003
7Breast Neoplasms (Breast Cancer)
11/2021 - 01/2002
6Fatigue
03/2016 - 06/2008
6Exanthema (Rash)
08/2013 - 08/2005
5Vomiting
03/2016 - 11/2005
5Disease Progression
01/2014 - 05/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 05/2003
4Febrile Neutropenia
06/2013 - 11/2009
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2016
2Anorexia
03/2016 - 04/2009
2Mucositis
02/2015 - 01/2010
2Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 04/2013
2Anemia
01/2014 - 06/2010
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2010 - 11/2009
2Lung Neoplasms (Lung Cancer)
05/2005 - 05/2003
1Microsatellite Instability
11/2021
1Carcinogenesis
05/2020
1Leiomyosarcoma
03/2016
1Pain (Aches)
12/2015
1Thrombocytopenia 1
02/2015
1Hemorrhage
02/2015
1Body Weight (Weight, Body)
01/2015
1Edema (Dropsy)
01/2014
1Uveitis
06/2013
1Proteinuria
11/2011

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
05/2020 - 08/2005
7Carboplatin (JM8)FDA LinkGeneric
12/2019 - 05/2003
5Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 05/2003
4Paclitaxel (Taxol)FDA LinkGeneric
09/2012 - 01/2002
4Lapatinib (GW572016)FDA Link
11/2009 - 08/2005
3Pemetrexed (MTA)FDA Link
12/2019 - 01/2010
3pazopanibFDA Link
08/2013 - 01/2010
3Transaminases (Aminotransferases)IBA
06/2013 - 01/2010
3GemcitabineFDA Link
07/2012 - 01/2011
3Trastuzumab (Herceptin)FDA Link
04/2009 - 08/2005
2Biomarkers (Surrogate Marker)IBA
11/2022 - 11/2021
2Immune Checkpoint InhibitorsIBA
11/2022 - 11/2021
2Proteins (Proteins, Gene)FDA Link
12/2015 - 06/2011
2EnzymesIBA
12/2015 - 08/2013
2romidepsin (FK228)FDA Link
12/2015 - 07/2012
2Capecitabine (Xeloda)FDA Link
01/2015 - 05/2010
2Tyrosine Kinase InhibitorsIBA
08/2013 - 04/2009
2PanobinostatIBA
09/2012 - 03/2011
2Topotecan (Hycamtin)FDA LinkGeneric
06/2010 - 01/2010
2ErbB Receptors (EGF Receptor)IBA
04/2009 - 08/2005
2Docetaxel (Taxotere)FDA Link
06/2008 - 05/2005
2Gefitinib (Iressa)FDA Link
09/2005 - 05/2003
1cyclopropapyrroloindoleIBA
11/2022
1adavosertibIBA
01/2022
1PlatinumIBA
01/2022
1HSP27 Heat-Shock ProteinsIBA
12/2019
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2019
1apatorsenIBA
12/2019
1Antisense OligonucleotidesIBA
12/2019
1Messenger RNA (mRNA)IBA
12/2019
1LY900009IBA
03/2016
1LipidsIBA
12/2015
1Cytochrome P-450 CYP3A InhibitorsIBA
12/2015
1Rifampin (Rifampicin)FDA LinkGeneric
12/2015
1Ketoconazole (Nizoral)FDA LinkGeneric
12/2015
1Cytochrome P-450 CYP3AIBA
12/2015
1Ranitidine (Zantac)FDA LinkGeneric
12/2015
1Focal Adhesion Protein-Tyrosine KinasesIBA
10/2015
1defactinibIBA
10/2015
1dactolisibIBA
04/2015
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
04/2015
1ME-344IBA
04/2015
1EverolimusFDA Link
02/2015
13- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
02/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2015
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
01/2015
1Biological ProductsIBA
07/2014
1ME-143IBA
02/2014
1NADH oxidaseIBA
02/2014
1human ALK1-Fc fusion proteinIBA
01/2014
1DiureticsIBA
01/2014
1LigandsIBA
01/2014
1Activin Receptors (Activin Receptor)IBA
01/2014
1carfilzomibIBA
10/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2013
1Proteasome InhibitorsIBA
10/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2013
1Epidermal Growth Factor (EGF)IBA
08/2013
1Monoclonal AntibodiesIBA
04/2013
1Glycoproteins (Glycoprotein)IBA
04/2013
1KRN-330IBA
04/2013
1Angiogenesis InhibitorsIBA
08/2012
1vatalanib (PTK787)IBA
11/2011
1Bevacizumab (Avastin)FDA Link
11/2011

Therapy/Procedure

10Therapeutics
03/2016 - 05/2003
4Drug Therapy (Chemotherapy)
01/2022 - 01/2011
1Precision Medicine
11/2022
1Time-to-Treatment
11/2021
1Premedication
01/2016
1Drug Tapering
08/2013
1Oral Administration
09/2012